No Prescription |
 |
 | ||
|
Anafranil Generic Clomipramine |
|
| ||
No Prescription » Prescription Drugs 1 » Anafranil Generic Clomipramine Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Anafranil« (clomipramine hydrochloride capsules USP) is an antiobsessional drug that belongs to the class (dibenzazepine) of pharmacologic agents known as tricyclic antidepressants. Anafranil is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD). The obsessions or compulsions must cause marked distress be time-consuming or significantly interfere with social or occupational functioning in order to meet the DSM-III-R (circa 1989) diagnosis of OCD. Obsessions are recurrent persistent ideas thoughts images or impulses that are ego-dystonic. Compulsions are repetitive purposeful and intentional behaviors performed in response to an obsession or in a stereotyped fashion and are recognized by the person as excessive or unreasonable. Treating obsessive-compulsive disorder (OCD). It may also be used for other conditions as determined by your doctor. Anafranil is a tricyclic antidepressant. It works by increasing the activity of certain chemicals in the brain which helps to reduce obsessive-compulsive behaviors. Clomipramine is used to treat symptoms of obsessive-compulsive disorder (OCD) such as recurrent thoughts or feelings and repetitive actions. Buy Anafranil Generic Clomipramine and other Prescription Drugs 1 products online at Medstore. Buy Online at Medstore - Click Here!
About Anafranil Generic Clomipramine: Product Type: Prescription Drugs 1 Anafranil ( Generic Clomipramine ) Anafranil (Generic Clomipramine) Generic Clomipramine 10mg 30 Tabs 90 ( 3 x 30 )Tabs 25mg 90 ( 3 x 30 )Tabs 25mg 30 Tabs Generic Clomipramine Anafranil
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
